title: Prevalence and characteristics of the epidemic multiresistant Escherichia coli ST131 clonal group among extended-spectrum beta-lactamase-producing E. coli isolates in Copenhagen, Denmark.
abstract: We report the characteristics of 115 extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli clinical isolates, from 115 unique Danish patients, over a 1-year study interval (1 October 2008 to 30 September 2009). Forty-four (38%) of the ESBL isolates represented sequence type 131 (ST13)1, from phylogenetic group B2. The remaining 71 isolates were from phylogenetic groups D (27%), A (22%), B1 (10%), and B2 (3%). Serogroup O25 ST131 isolates (n = 42; 95% of ST131) comprised 7 different K antigens, whereas two ST131 isolates were O16:K100:H5. Compared to non-ST131 isolates, ST131 isolates were associated positively with CTX-M-15 and negatively with CTX-M-1 and CTX-M-14. They also were associated positively with 11 virulence genes, including afa and dra (Dr family adhesins), the F10 papA allele (P fimbria variant), fimH (type 1 fimbriae), fyuA (yersiniabactin receptor), iha (adhesin siderophore), iutA (aerobactin receptor), kpsM II (group 2 capsules), malX (pathogenicity island marker), ompT (outer membrane protease), sat (secreted autotransporter toxin), and usp (uropathogenicity-specific protein) and negatively with hra (heat-resistant agglutinin) and iroN (salmochelin receptor). The consensus virulence gene profile (>90% prevalence) of the ST131 isolates included fimH, fyuA, malX, and usp (100% each), ompT and the F10 papA allele (95% each), and kpsM II and iutA (93% each). ST131 isolates were also positively associated with community acquisition, extraintestinal pathogenic E. coli (ExPEC) status, and the O25, K100, and H4 antigens. Thus, among ESBL E. coli isolates in Copenhagen, ST131 was the most prevalent clonal group, was community associated, and exhibited distinctive and comparatively extensive virulence profiles, plus a greater variety of capsular antigens than reported previously.
authors.affiliation: Department of Clinical Microbiology, Hillerød Hospital, Hillerød, Denmark. bente.olesen@regionh.dk
authors.forename: Bente
authors.initials: B
authors.lastname: Olesen
authors.forename: Dennis S
authors.initials: DS
authors.lastname: Hansen
authors.forename: Frida
authors.initials: F
authors.lastname: Nilsson
authors.forename: Jakob
authors.initials: J
authors.lastname: Frimodt-Møller
authors.forename: Rikke Fleron
authors.initials: RF
authors.lastname: Leihof
authors.forename: Carsten
authors.initials: C
authors.lastname: Struve
authors.forename: Flemming
authors.initials: F
authors.lastname: Scheutz
authors.forename: Brian
authors.initials: B
authors.lastname: Johnston
authors.forename: Karen A
authors.initials: KA
authors.lastname: Krogfelt
authors.forename: James R
authors.initials: JR
authors.lastname: Johnson
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002648:Child; D002675:Child, Preschool; D003718:Denmark / Q000453:epidemiology; D058872:Epidemics; D004926:Escherichia coli / Q000145:classification* / Q000201:enzymology / Q000235:genetics* / Q000302:isolation & purification; D004927:Escherichia coli Infections / Q000453:epidemiology* / Q000382:microbiology*; D005260:Female; D005838:Genotype; D006801:Humans; D007223:Infant; D008297:Male; D008875:Middle Aged; D017720:Molecular Epidemiology; D015995:Prevalence; D012703:Serotyping; D037521:Virulence Factors / Q000235:genetics; D055815:Young Adult; D001618:beta-Lactamases / Q000378:metabolism*
chemical_list: D037521:Virulence Factors; D001618:beta-Lactamases
references.citation: Emerg Infect Dis. 2005 Jan;11(1):141-5
references.pmid: 15705341
references.citation: J Clin Microbiol. 1989 Nov;27(11):2559-64
references.pmid: 2681256
references.citation: Microbes Infect. 2006 Jun;8(7):1702-13
references.pmid: 16820314
references.citation: J Infect Dis. 2012 Feb 1;205(3):431-44
references.pmid: 22184729
references.citation: Appl Environ Microbiol. 2010 May;76(9):2799-805
references.pmid: 20228098
references.citation: Antimicrob Agents Chemother. 2012 May;56(5):2364-70
references.pmid: 22354301
references.citation: Foodborne Pathog Dis. 2006 Spring;3(1):59-67
references.pmid: 16602980
references.citation: J Antimicrob Chemother. 2011 Mar;66(3):517-26
references.pmid: 21177675
references.citation: Antimicrob Agents Chemother. 2009 Jul;53(7):2733-9
references.pmid: 19398649
references.citation: J Clin Microbiol. 2009 Jun;47(6):1857-62
references.pmid: 19339467
references.citation: Curr Opin Microbiol. 2006 Oct;9(5):466-75
references.pmid: 16942899
references.citation: Ann Intern Med. 2002 Nov 19;137(10):791-7
references.pmid: 12435215
references.citation: J Antimicrob Chemother. 2009 Aug;64(2):274-7
references.pmid: 19474064
references.citation: J Clin Microbiol. 2005 Dec;43(12):5860-4
references.pmid: 16333067
references.citation: J Clin Microbiol. 2004 Apr;42(4):1773-6
references.pmid: 15071046
references.citation: J Antimicrob Chemother. 2012 Nov;67(11):2612-20
references.pmid: 22843833
references.citation: Antimicrob Agents Chemother. 2011 Nov;55(11):4971-8
references.pmid: 21859935
references.citation: APMIS. 2009 Jul;117(7):526-36
references.pmid: 19594493
references.citation: Appl Environ Microbiol. 2012 Feb;78(4):1198-202
references.pmid: 22156422
references.citation: Infect Immun. 2013 Apr;81(4):1164-71
references.pmid: 23357383
references.citation: Infect Immun. 1977 Dec;18(3):775-9
references.pmid: 338490
references.citation: Antimicrob Agents Chemother. 2010 Mar;54(3):1327-30
references.pmid: 20047913
references.citation: J Antimicrob Chemother. 2011 Nov;66(11):2501-8
references.pmid: 21862477
references.citation: Int J Antimicrob Agents. 2010 Oct;36(4):355-8
references.pmid: 20691573
references.citation: J Antimicrob Chemother. 2013 Apr;68(4):758-65
references.pmid: 23221627
references.citation: J Antimicrob Chemother. 2011 Jan;66(1):1-14
references.pmid: 21081548
references.citation: J Clin Microbiol. 2004 Jun;42(6):2618-22
references.pmid: 15184442
references.citation: Infect Immun. 2000 Mar;68(3):1587-99
references.pmid: 10678978
references.citation: Diagn Microbiol Infect Dis. 2007 Feb;57(2):129-36
references.pmid: 17020797
references.citation: Antimicrob Agents Chemother. 2003 Jul;47(7):2161-8
references.pmid: 12821463
references.citation: Int J Antimicrob Agents. 2010 Apr;35(4):316-21
references.pmid: 20060273
references.citation: J Clin Microbiol. 1995 Sep;33(9):2233-9
references.pmid: 7494007
references.citation: Int J Antimicrob Agents. 2011 Aug;38(2):180-2
references.pmid: 21612893
references.citation: J Infect Dis. 2000 Jan;181(1):261-72
references.pmid: 10608775
references.citation: Eur J Clin Microbiol Infect Dis. 2013 Mar;32(3):431-6
references.pmid: 23129461
references.citation: J Clin Microbiol. 2012 Nov;50(11):3703-11
references.pmid: 22972830
references.citation: Antimicrob Agents Chemother. 2005 Nov;49(11):4667-70
references.pmid: 16251310